Global and United States Tumor Necrosis Factor Inhibitor Drug Market Insights, Forecast to 2031

Report ID: 1025234 | Published Date: Sep 2024 | No. of Page: 147 | Base Year: 2023 | Rating: 4.6 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Tumor Necrosis Factor Inhibitor Drug Product Introduction
    1.2 Market by Type
        1.2.1 Global Tumor Necrosis Factor Inhibitor Drug Market Size Growth Rate by Type
        1.2.2 Humira
        1.2.3 Enbrel
        1.2.4 Remicade
        1.2.5 Simponi
        1.2.6 Cimzia
        1.2.7 Biosimilars
    1.3 Market by Application
        1.3.1 Global Tumor Necrosis Factor Inhibitor Drug Market Size Growth Rate by Application
        1.3.2 Rheumatoid Arthritis
        1.3.3 Psoriatic Arthritis
        1.3.4 Juvenile Idiopathic Arthritis
        1.3.5 Crohn’s Disease
        1.3.6 Ulcerative Colitis
        1.3.7 Others
    1.4 Study Objectives
    1.5 Years Considered

2 Executive Summary
    2.1 Global Tumor Necrosis Factor Inhibitor Drug Market Size, Estimates and Forecasts
        2.1.1 Global Tumor Necrosis Factor Inhibitor Drug Revenue 2016-2027
        2.1.2 Global Tumor Necrosis Factor Inhibitor Drug Sales 2016-2027
    2.2 Global Tumor Necrosis Factor Inhibitor Drug, Market Size by Region: 2016 VS 2021 VS 2027
    2.3 Tumor Necrosis Factor Inhibitor Drug Historical Market Size by Region (2016-2021)
        2.3.1 Global Tumor Necrosis Factor Inhibitor Drug Retrospective Market Scenario in Sales by Region: 2016-2021
        2.3.2 Global Tumor Necrosis Factor Inhibitor Drug Retrospective Market Scenario in Revenue by Region: 2016-2021
    2.4 Tumor Necrosis Factor Inhibitor Drug Market Estimates and Projections by Region (2022-2027)
        2.4.1 Global Tumor Necrosis Factor Inhibitor Drug Sales Forecast by Region (2022-2027)
        2.4.2 Global Tumor Necrosis Factor Inhibitor Drug Revenue Forecast by Region (2022-2027)

3 Global Tumor Necrosis Factor Inhibitor Drug Competitor Landscape by Players
    3.1 Global Top Tumor Necrosis Factor Inhibitor Drug Manufacturers by Sales
        3.1.1 Global Tumor Necrosis Factor Inhibitor Drug Sales by Manufacturer (2016-2021)
        3.1.2 Global Tumor Necrosis Factor Inhibitor Drug Sales Market Share by Manufacturer (2016-2021)
    3.2 Global Top Tumor Necrosis Factor Inhibitor Drug Manufacturers by Revenue
        3.2.1 Key Tumor Necrosis Factor Inhibitor Drug Manufacturers Covered: Ranking by Revenue
        3.2.2 Global Tumor Necrosis Factor Inhibitor Drug Revenue by Manufacturers (2016-2021)
        3.2.3 Global Tumor Necrosis Factor Inhibitor Drug Revenue Share by Manufacturers (2016-2021)
        3.2.4 Global Tumor Necrosis Factor Inhibitor Drug Market Concentration Ratio (CR5 and HHI) (2016-2021)
        3.2.5 Global Top 10 and Top 5 Companies by Tumor Necrosis Factor Inhibitor Drug Revenue in 2020
        3.2.6 Global Tumor Necrosis Factor Inhibitor Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Global Tumor Necrosis Factor Inhibitor Drug Price by Manufacturers
    3.4 Global Tumor Necrosis Factor Inhibitor Drug Manufacturing Base Distribution, Product Types
        3.4.1 Tumor Necrosis Factor Inhibitor Drug Manufacturers Manufacturing Base Distribution, Headquarters
        3.4.2 Manufacturers Tumor Necrosis Factor Inhibitor Drug Product Type
        3.4.3 Date of International Manufacturers Enter into Tumor Necrosis Factor Inhibitor Drug Market
    3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2016-2027)
    4.1 Global Tumor Necrosis Factor Inhibitor Drug Market Size by Type (2016-2021)
        4.1.1 Global Tumor Necrosis Factor Inhibitor Drug Sales by Type (2016-2021)
        4.1.2 Global Tumor Necrosis Factor Inhibitor Drug Revenue by Type (2016-2021)
        4.1.3 Tumor Necrosis Factor Inhibitor Drug Average Selling Price (ASP) by Type (2016-2021)
    4.2 Global Tumor Necrosis Factor Inhibitor Drug Market Size Forecast by Type (2022-2027)
        4.2.1 Global Tumor Necrosis Factor Inhibitor Drug Sales Forecast by Type (2022-2027)
        4.2.2 Global Tumor Necrosis Factor Inhibitor Drug Revenue Forecast by Type (2022-2027)
        4.2.3 Tumor Necrosis Factor Inhibitor Drug Average Selling Price (ASP) Forecast by Type (2022-2027)

5 Breakdown Data by Application (2016-2027)
    5.1 Global Tumor Necrosis Factor Inhibitor Drug Market Size by Application (2016-2021)
        5.1.1 Global Tumor Necrosis Factor Inhibitor Drug Sales by Application (2016-2021)
        5.1.2 Global Tumor Necrosis Factor Inhibitor Drug Revenue by Application (2016-2021)
        5.1.3 Tumor Necrosis Factor Inhibitor Drug Price by Application (2016-2021)
    5.2 Tumor Necrosis Factor Inhibitor Drug Market Size Forecast by Application (2022-2027)
        5.2.1 Global Tumor Necrosis Factor Inhibitor Drug Sales Forecast by Application (2022-2027)
        5.2.2 Global Tumor Necrosis Factor Inhibitor Drug Revenue Forecast by Application (2022-2027)
        5.2.3 Global Tumor Necrosis Factor Inhibitor Drug Price Forecast by Application (2022-2027)

6 United States by Players, Type and Application
    6.1 United States Tumor Necrosis Factor Inhibitor Drug Market Size YoY Growth 2016-2027
        6.1.1 United States Tumor Necrosis Factor Inhibitor Drug Sales YoY Growth 2016-2027
        6.1.2 United States Tumor Necrosis Factor Inhibitor Drug Revenue YoY Growth 2016-2027
        6.1.3 United States Tumor Necrosis Factor Inhibitor Drug Market Share in Global Market 2016-2027
    6.2 United States Tumor Necrosis Factor Inhibitor Drug Market Size by Players (International and Local Players)
        6.2.1 United States Top Tumor Necrosis Factor Inhibitor Drug Players by Sales (2016-2021)
        6.2.2 United States Top Tumor Necrosis Factor Inhibitor Drug Players by Revenue (2016-2021)
    6.3 United States Tumor Necrosis Factor Inhibitor Drug Historic Market Review by Type (2016-2021)
        6.3.1 United States Tumor Necrosis Factor Inhibitor Drug Sales Market Share by Type (2016-2021)
        6.3.2 United States Tumor Necrosis Factor Inhibitor Drug Revenue Market Share by Type (2016-2021)
        6.3.3 United States Tumor Necrosis Factor Inhibitor Drug Price by Type (2016-2021)
    6.4 United States Tumor Necrosis Factor Inhibitor Drug Market Estimates and Forecasts by Type (2022-2027)
        6.4.1 United States Tumor Necrosis Factor Inhibitor Drug Sales Forecast by Type (2022-2027)
        6.4.2 United States Tumor Necrosis Factor Inhibitor Drug Revenue Forecast by Type (2022-2027)
        6.4.3 United States Tumor Necrosis Factor Inhibitor Drug Price Forecast by Type (2022-2027)
    6.5 United States Tumor Necrosis Factor Inhibitor Drug Historic Market Review by Application (2016-2021)
        6.5.1 United States Tumor Necrosis Factor Inhibitor Drug Sales Market Share by Application (2016-2021)
        6.5.2 United States Tumor Necrosis Factor Inhibitor Drug Revenue Market Share by Application (2016-2021)
        6.5.3 United States Tumor Necrosis Factor Inhibitor Drug Price by Application (2016-2021)
    6.6 United States Tumor Necrosis Factor Inhibitor Drug Market Estimates and Forecasts by Application (2022-2027)
        6.6.1 United States Tumor Necrosis Factor Inhibitor Drug Sales Forecast by Application (2022-2027)
        6.6.2 United States Tumor Necrosis Factor Inhibitor Drug Revenue Forecast by Application (2022-2027)
        6.6.3 United States Tumor Necrosis Factor Inhibitor Drug Price Forecast by Application (2022-2027)

7 North America
    7.1 North America Tumor Necrosis Factor Inhibitor Drug Market Size YoY Growth 2016-2027
    7.2 North America Tumor Necrosis Factor Inhibitor Drug Market Facts & Figures by Country
        7.2.1 North America Tumor Necrosis Factor Inhibitor Drug Sales by Country (2016-2021)
        7.2.2 North America Tumor Necrosis Factor Inhibitor Drug Revenue by Country (2016-2021)
        7.2.3 United States
        7.2.4 Canada

8 Asia Pacific
    8.1 Asia Pacific Tumor Necrosis Factor Inhibitor Drug Market Size YoY Growth 2016-2027
    8.2 Asia Pacific Tumor Necrosis Factor Inhibitor Drug Market Facts & Figures by Region
        8.2.1 Asia Pacific Tumor Necrosis Factor Inhibitor Drug Sales by Region (2016-2021)
        8.2.2 Asia Pacific Tumor Necrosis Factor Inhibitor Drug Revenue by Region (2016-2021)
        8.2.3 China
        8.2.4 Japan
        8.2.5 South Korea
        8.2.6 India
        8.2.7 Australia
        8.2.8 Australia
        8.2.9 Indonesia
        8.2.10 Thailand
        8.2.11 Malaysia

9 Europe
    9.1 Europe Tumor Necrosis Factor Inhibitor Drug Market Size YoY Growth 2016-2027
    9.2 Europe Tumor Necrosis Factor Inhibitor Drug Market Facts & Figures by Country
        9.2.1 Europe Tumor Necrosis Factor Inhibitor Drug Sales by Country (2016-2021)
        9.2.2 Europe Tumor Necrosis Factor Inhibitor Drug Revenue by Country (2016-2021)
        9.2.3 Germany
        9.2.4 France
        9.2.5 U.K.
        9.2.6 Italy

10 Latin America
    10.1 Latin America Tumor Necrosis Factor Inhibitor Drug Market Size YoY Growth 2016-2027
    10.2 Latin America Tumor Necrosis Factor Inhibitor Drug Market Facts & Figures by Country
        10.2.1 Latin America Tumor Necrosis Factor Inhibitor Drug Sales by Country (2016-2021)
        10.2.2 Latin America Tumor Necrosis Factor Inhibitor Drug Revenue by Country (2016-2021)
        10.2.3 Mexico
        10.2.4 Brazil
        10.2.5 Argentina

11 Middle East and Africa
    11.1 Middle East and Africa Tumor Necrosis Factor Inhibitor Drug Market Size YoY Growth 2016-2027
    11.2 Middle East and Africa Tumor Necrosis Factor Inhibitor Drug Market Facts & Figures by Country
        11.2.1 Middle East and Africa Tumor Necrosis Factor Inhibitor Drug Sales by Country (2016-2021)
        11.2.2 Middle East and Africa Tumor Necrosis Factor Inhibitor Drug Revenue by Country (2016-2021)
        11.2.3 Turkey
        11.2.4 Saudi Arabia
        11.2.5 UAE

12 Company Profiles
    12.1 AbbVie Inc.
        12.1.1 AbbVie Inc. Corporation Information
        12.1.2 AbbVie Inc. Description and Business Overview
        12.1.3 AbbVie Inc. Tumor Necrosis Factor Inhibitor Drug Sales, Revenue and Gross Margin (2016-2021)
        12.1.4 AbbVie Inc. Tumor Necrosis Factor Inhibitor Drug Products Offered
        12.1.5 AbbVie Inc. Recent Development
    12.2 Amgen Inc.
        12.2.1 Amgen Inc. Corporation Information
        12.2.2 Amgen Inc. Description and Business Overview
        12.2.3 Amgen Inc. Tumor Necrosis Factor Inhibitor Drug Sales, Revenue and Gross Margin (2016-2021)
        12.2.4 Amgen Inc. Tumor Necrosis Factor Inhibitor Drug Products Offered
        12.2.5 Amgen Inc. Recent Development
    12.3 Johnson & Johnson
        12.3.1 Johnson & Johnson Corporation Information
        12.3.2 Johnson & Johnson Description and Business Overview
        12.3.3 Johnson & Johnson Tumor Necrosis Factor Inhibitor Drug Sales, Revenue and Gross Margin (2016-2021)
        12.3.4 Johnson & Johnson Tumor Necrosis Factor Inhibitor Drug Products Offered
        12.3.5 Johnson & Johnson Recent Development
    12.4 UCB
        12.4.1 UCB Corporation Information
        12.4.2 UCB Description and Business Overview
        12.4.3 UCB Tumor Necrosis Factor Inhibitor Drug Sales, Revenue and Gross Margin (2016-2021)
        12.4.4 UCB Tumor Necrosis Factor Inhibitor Drug Products Offered
        12.4.5 UCB Recent Development
    12.5 Novartis AG
        12.5.1 Novartis AG Corporation Information
        12.5.2 Novartis AG Description and Business Overview
        12.5.3 Novartis AG Tumor Necrosis Factor Inhibitor Drug Sales, Revenue and Gross Margin (2016-2021)
        12.5.4 Novartis AG Tumor Necrosis Factor Inhibitor Drug Products Offered
        12.5.5 Novartis AG Recent Development
    12.6 Pfizer, Inc.
        12.6.1 Pfizer, Inc. Corporation Information
        12.6.2 Pfizer, Inc. Description and Business Overview
        12.6.3 Pfizer, Inc. Tumor Necrosis Factor Inhibitor Drug Sales, Revenue and Gross Margin (2016-2021)
        12.6.4 Pfizer, Inc. Tumor Necrosis Factor Inhibitor Drug Products Offered
        12.6.5 Pfizer, Inc. Recent Development
    12.7 Merck & Co., Inc.
        12.7.1 Merck & Co., Inc. Corporation Information
        12.7.2 Merck & Co., Inc. Description and Business Overview
        12.7.3 Merck & Co., Inc. Tumor Necrosis Factor Inhibitor Drug Sales, Revenue and Gross Margin (2016-2021)
        12.7.4 Merck & Co., Inc. Tumor Necrosis Factor Inhibitor Drug Products Offered
        12.7.5 Merck & Co., Inc. Recent Development
    12.8 CASI Pharmaceuticals
        12.8.1 CASI Pharmaceuticals Corporation Information
        12.8.2 CASI Pharmaceuticals Description and Business Overview
        12.8.3 CASI Pharmaceuticals Tumor Necrosis Factor Inhibitor Drug Sales, Revenue and Gross Margin (2016-2021)
        12.8.4 CASI Pharmaceuticals Tumor Necrosis Factor Inhibitor Drug Products Offered
        12.8.5 CASI Pharmaceuticals Recent Development
    12.9 EPIRUS Biopharmaceuticals
        12.9.1 EPIRUS Biopharmaceuticals Corporation Information
        12.9.2 EPIRUS Biopharmaceuticals Description and Business Overview
        12.9.3 EPIRUS Biopharmaceuticals Tumor Necrosis Factor Inhibitor Drug Sales, Revenue and Gross Margin (2016-2021)
        12.9.4 EPIRUS Biopharmaceuticals Tumor Necrosis Factor Inhibitor Drug Products Offered
        12.9.5 EPIRUS Biopharmaceuticals Recent Development
    12.10 LEO Pharma
        12.10.1 LEO Pharma Corporation Information
        12.10.2 LEO Pharma Description and Business Overview
        12.10.3 LEO Pharma Tumor Necrosis Factor Inhibitor Drug Sales, Revenue and Gross Margin (2016-2021)
        12.10.4 LEO Pharma Tumor Necrosis Factor Inhibitor Drug Products Offered
        12.10.5 LEO Pharma Recent Development
    12.11 AbbVie Inc.
        12.11.1 AbbVie Inc. Corporation Information
        12.11.2 AbbVie Inc. Description and Business Overview
        12.11.3 AbbVie Inc. Tumor Necrosis Factor Inhibitor Drug Sales, Revenue and Gross Margin (2016-2021)
        12.11.4 AbbVie Inc. Tumor Necrosis Factor Inhibitor Drug Products Offered
        12.11.5 AbbVie Inc. Recent Development
    12.12 Shanghai Pharmaceuticals Holding Co., Ltd.
        12.12.1 Shanghai Pharmaceuticals Holding Co., Ltd. Corporation Information
        12.12.2 Shanghai Pharmaceuticals Holding Co., Ltd. Description and Business Overview
        12.12.3 Shanghai Pharmaceuticals Holding Co., Ltd. Tumor Necrosis Factor Inhibitor Drug Sales, Revenue and Gross Margin (2016-2021)
        12.12.4 Shanghai Pharmaceuticals Holding Co., Ltd. Products Offered
        12.12.5 Shanghai Pharmaceuticals Holding Co., Ltd. Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
    13.1 Tumor Necrosis Factor Inhibitor Drug Industry Trends
    13.2 Tumor Necrosis Factor Inhibitor Drug Market Drivers
    13.3 Tumor Necrosis Factor Inhibitor Drug Market Challenges
    13.4 Tumor Necrosis Factor Inhibitor Drug Market Restraints

14 Value Chain and Sales Channels Analysis
    14.1 Value Chain Analysis
    14.2 Tumor Necrosis Factor Inhibitor Drug Customers
    14.3 Sales Channels Analysis
        14.3.1 Sales Channels
        14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
    16.1 Research Methodology
        16.1.1 Methodology/Research Approach
        16.1.2 Data Source
    16.2 Author Details
    16.3 Disclaimer
List of Tables
    Table 1. Global Tumor Necrosis Factor Inhibitor Drug Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
    Table 2. Major Manufacturers of Humira
    Table 3. Major Manufacturers of Enbrel
    Table 4. Major Manufacturers of Remicade
    Table 5. Major Manufacturers of Simponi
    Table 6. Major Manufacturers of Cimzia
    Table 7. Major Manufacturers of Biosimilars
    Table 8. Global Tumor Necrosis Factor Inhibitor Drug Market Size Growth Rate by Application (2021-2027) & (K Units)
    Table 9. Global Tumor Necrosis Factor Inhibitor Drug Market Size by Region (K Units) & (US$ Million), 2016 VS 2021 VS 2027
    Table 10. Global Tumor Necrosis Factor Inhibitor Drug Sales by Regions (2016-2021) & (K Units)
    Table 11. Global Tumor Necrosis Factor Inhibitor Drug Sales Market Share by Regions (2016-2021)
    Table 12. Global Tumor Necrosis Factor Inhibitor Drug Revenue by Regions (2016-2021) & (US$ Million)
    Table 13. Global Tumor Necrosis Factor Inhibitor Drug Sales Forecast by Region (2022-2027) & (K Units)
    Table 14. Global Tumor Necrosis Factor Inhibitor Drug Sales Market Share Forecast by Region (2022-2027)
    Table 15. Global Tumor Necrosis Factor Inhibitor Drug Revenue Forecast by Region (2022-2027) & (US$ Million)
    Table 16. Global Tumor Necrosis Factor Inhibitor Drug Revenue Market Share Forecast by Region (2022-2027)
    Table 17. Global Tumor Necrosis Factor Inhibitor Drug Sales by Manufacturers (2016-2021) (K Units)
    Table 18. Global Tumor Necrosis Factor Inhibitor Drug Sales Share by Manufacturers (2016-2021)
    Table 19. Ranking of Global Top Tumor Necrosis Factor Inhibitor Drug Manufacturers by Revenue (US$ Million) in 2020
    Table 20. Tumor Necrosis Factor Inhibitor Drug Revenue by Manufacturers (2016-2021) (US$ Million)
    Table 21. Tumor Necrosis Factor Inhibitor Drug Revenue Share by Manufacturers (2016-2021)
    Table 22. Global Tumor Necrosis Factor Inhibitor Drug Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
    Table 23. Global Tumor Necrosis Factor Inhibitor Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tumor Necrosis Factor Inhibitor Drug as of 2020)
    Table 24. Key Manufacturers Tumor Necrosis Factor Inhibitor Drug Price (2016-2021) (US$/Unit)
    Table 25. Tumor Necrosis Factor Inhibitor Drug Manufacturers Manufacturing Base Distribution and Headquarters
    Table 26. Manufacturers Tumor Necrosis Factor Inhibitor Drug Product Type
    Table 27. Date of International Manufacturers Enter into Tumor Necrosis Factor Inhibitor Drug Market
    Table 28. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 29. Global Tumor Necrosis Factor Inhibitor Drug Sales by Type (2016-2021) (K Units)
    Table 30. Global Tumor Necrosis Factor Inhibitor Drug Sales Share by Type (2016-2021)
    Table 31. Global Tumor Necrosis Factor Inhibitor Drug Revenue by Type (2016-2021) (US$ Million)
    Table 32. Global Tumor Necrosis Factor Inhibitor Drug Revenue Share by Type (2016-2021)
    Table 33. Tumor Necrosis Factor Inhibitor Drug Average Selling Price (ASP) by Type (2016-2021) & (US$/Unit)
    Table 34. Global Tumor Necrosis Factor Inhibitor Drug Sales Forecast by Type (2022-2027) & (K Units)
    Table 35. Global Tumor Necrosis Factor Inhibitor Drug Sales Market Share Forecast by Type (2022-2027)
    Table 36. Global Tumor Necrosis Factor Inhibitor Drug Revenue Forecast V (2022-2027) & (US$ Million)
    Table 37. Global Tumor Necrosis Factor Inhibitor Drug Revenue Market Share Forecast by Type (2022-2027)
    Table 38. Global Tumor Necrosis Factor Inhibitor Drug Average Selling Price (ASP) Forecast by Type (2022-2027) & (US$/Unit)
    Table 39. Global Tumor Necrosis Factor Inhibitor Drug Sales by Application (2016-2021) (K Units)
    Table 40. Global Tumor Necrosis Factor Inhibitor Drug Sales Share by Application (2016-2021)
    Table 41. Global Tumor Necrosis Factor Inhibitor Drug Revenue by Application (2016-2021) (US$ Million)
    Table 42. Global Tumor Necrosis Factor Inhibitor Drug Revenue Share by Application (2016-2021)
    Table 43. Tumor Necrosis Factor Inhibitor Drug Average Selling Price (ASP) by Application (2016-2021) & (US$/Unit)
    Table 44. Global Tumor Necrosis Factor Inhibitor Drug Sales Forecast by Application (2022-2027) & (K Units)
    Table 45. Global Tumor Necrosis Factor Inhibitor Drug Sales Market Share Forecast by Application (2022-2027)
    Table 46. Global Tumor Necrosis Factor Inhibitor Drug Revenue Forecast by Application (2022-2027) & (US$ Million)
    Table 47. Global Tumor Necrosis Factor Inhibitor Drug Revenue Market Share Forecast by Application (2022-2027)
    Table 48. Global Tumor Necrosis Factor Inhibitor Drug Average Selling Price (ASP) Forecast by Application (2022-2027) & (US$/Unit)
    Table 49. United States Tumor Necrosis Factor Inhibitor Drug Sales (K Units) of Key Companies (2016-2021)
    Table 50. United States Tumor Necrosis Factor Inhibitor Drug Sales Share by Company (2016-2021)
    Table 51. United States Tumor Necrosis Factor Inhibitor Drug Revenue (US$ Million) by Company (2016-2021)
    Table 52. United States Tumor Necrosis Factor Inhibitor Drug Revenue Share by Company (2016-2021)
    Table 53. United States Tumor Necrosis Factor Inhibitor Drug Sales (K Units) by Type (2016-2021)
    Table 54. United States Tumor Necrosis Factor Inhibitor Drug Sales Share by Type (2016-2021)
    Table 55. United States Tumor Necrosis Factor Inhibitor Drug Revenue (US$ Million) Market Share by Type (2016-2021)
    Table 56. United States Tumor Necrosis Factor Inhibitor Drug Price (US$/Unit) by Type (2016-2021)
    Table 57. United States Tumor Necrosis Factor Inhibitor Drug Sales (K Units) by Type (2022-2027)
    Table 58. United States Tumor Necrosis Factor Inhibitor Drug Sales Share by Type (2022-2027)
    Table 59. United States Tumor Necrosis Factor Inhibitor Drug Revenue (US$ Million) Market Share by Type (2022-2027)
    Table 60. United States Tumor Necrosis Factor Inhibitor Drug Revenue Share by Type (2022-2027)
    Table 61. United States Tumor Necrosis Factor Inhibitor Drug Price (US$/Unit) by Type (2022-2027)
    Table 62. United States Tumor Necrosis Factor Inhibitor Drug Sales (K Units) by Application (2016-2021)
    Table 63. United States Tumor Necrosis Factor Inhibitor Drug Sales Share by Application (2016-2021)
    Table 64. United States Tumor Necrosis Factor Inhibitor Drug Revenue (US$ Million) Market Share by Application (2016-2021)
    Table 65. United States Tumor Necrosis Factor Inhibitor Drug Price (US$/Unit) by Application (2016-2021)
    Table 66. United States Tumor Necrosis Factor Inhibitor Drug Sales (K Units) by Application (2022-2027)
    Table 67. United States Tumor Necrosis Factor Inhibitor Drug Sales Share by Application (2022-2027)
    Table 68. United States Tumor Necrosis Factor Inhibitor Drug Revenue (US$ Million) Market Share by Application (2022-2027)
    Table 69. United States Tumor Necrosis Factor Inhibitor Drug Revenue Share by Application (2022-2027)
    Table 70. United States Tumor Necrosis Factor Inhibitor Drug Price (US$/Unit) by Application (2022-2027)
    Table 71. North America Tumor Necrosis Factor Inhibitor Drug Sales by Country (2016-2021) & (K Units)
    Table 72. North America Tumor Necrosis Factor Inhibitor Drug Sales Market Share by Country (2016-2021)
    Table 73. North America Tumor Necrosis Factor Inhibitor Drug Revenue by Country (2016-2021) & (US$ Million)
    Table 74. North America Tumor Necrosis Factor Inhibitor Drug Revenue Market Share by Country (2016-2021)
    Table 75. Asia Pacific Tumor Necrosis Factor Inhibitor Drug Sales by Region (2016-2021) & (K Units)
    Table 76. Asia Pacific Tumor Necrosis Factor Inhibitor Drug Sales Market Share by Region (2016-2021)
    Table 77. Asia Pacific Tumor Necrosis Factor Inhibitor Drug Revenue by Region (2016-2021) & (US$ Million)
    Table 78. Asia Pacific Tumor Necrosis Factor Inhibitor Drug Revenue Market Share by Region (2016-2021)
    Table 79. Europe Tumor Necrosis Factor Inhibitor Drug Sales by Country (2016-2021) & (K Units)
    Table 80. Europe Tumor Necrosis Factor Inhibitor Drug Sales Market Share by Country (2016-2021)
    Table 81. Europe Tumor Necrosis Factor Inhibitor Drug Revenue by Country (2016-2021) & (US$ Million)
    Table 82. Europe Tumor Necrosis Factor Inhibitor Drug Revenue Market Share by Country (2016-2021)
    Table 83. Latin America Tumor Necrosis Factor Inhibitor Drug Sales by Country (2016-2021) & (K Units)
    Table 84. Latin America Tumor Necrosis Factor Inhibitor Drug Sales Market Share by Country (2016-2021)
    Table 85. Latin Americaa Tumor Necrosis Factor Inhibitor Drug Revenue by Country (2016-2021) & (US$ Million)
    Table 86. Latin America Tumor Necrosis Factor Inhibitor Drug Revenue Market Share by Country (2016-2021)
    Table 87. Middle East and Africa Tumor Necrosis Factor Inhibitor Drug Sales by Country (2016-2021) & (K Units)
    Table 88. Middle East and Africa Tumor Necrosis Factor Inhibitor Drug Sales Market Share by Country (2016-2021)
    Table 89. Middle East and Africa Tumor Necrosis Factor Inhibitor Drug Revenue by Country (2016-2021) & (US$ Million)
    Table 90. Middle East and Africa Tumor Necrosis Factor Inhibitor Drug Revenue Market Share by Country (2016-2021)
    Table 91. AbbVie Inc. Corporation Information
    Table 92. AbbVie Inc. Description and Business Overview
    Table 93. AbbVie Inc. Tumor Necrosis Factor Inhibitor Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 94. AbbVie Inc. Tumor Necrosis Factor Inhibitor Drug Product
    Table 95. AbbVie Inc. Recent Development
    Table 96. Amgen Inc. Corporation Information
    Table 97. Amgen Inc. Description and Business Overview
    Table 98. Amgen Inc. Tumor Necrosis Factor Inhibitor Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 99. Amgen Inc. Product
    Table 100. Amgen Inc. Recent Development
    Table 101. Johnson & Johnson Corporation Information
    Table 102. Johnson & Johnson Description and Business Overview
    Table 103. Johnson & Johnson Tumor Necrosis Factor Inhibitor Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 104. Johnson & Johnson Product
    Table 105. Johnson & Johnson Recent Development
    Table 106. UCB Corporation Information
    Table 107. UCB Description and Business Overview
    Table 108. UCB Tumor Necrosis Factor Inhibitor Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 109. UCB Product
    Table 110. UCB Recent Development
    Table 111. Novartis AG Corporation Information
    Table 112. Novartis AG Description and Business Overview
    Table 113. Novartis AG Tumor Necrosis Factor Inhibitor Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 114. Novartis AG Product
    Table 115. Novartis AG Recent Development
    Table 116. Pfizer, Inc. Corporation Information
    Table 117. Pfizer, Inc. Description and Business Overview
    Table 118. Pfizer, Inc. Tumor Necrosis Factor Inhibitor Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 119. Pfizer, Inc. Product
    Table 120. Pfizer, Inc. Recent Development
    Table 121. Merck & Co., Inc. Corporation Information
    Table 122. Merck & Co., Inc. Description and Business Overview
    Table 123. Merck & Co., Inc. Tumor Necrosis Factor Inhibitor Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 124. Merck & Co., Inc. Product
    Table 125. Merck & Co., Inc. Recent Development
    Table 126. CASI Pharmaceuticals Corporation Information
    Table 127. CASI Pharmaceuticals Description and Business Overview
    Table 128. CASI Pharmaceuticals Tumor Necrosis Factor Inhibitor Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 129. CASI Pharmaceuticals Product
    Table 130. CASI Pharmaceuticals Recent Development
    Table 131. EPIRUS Biopharmaceuticals Corporation Information
    Table 132. EPIRUS Biopharmaceuticals Description and Business Overview
    Table 133. EPIRUS Biopharmaceuticals Tumor Necrosis Factor Inhibitor Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 134. EPIRUS Biopharmaceuticals Product
    Table 135. EPIRUS Biopharmaceuticals Recent Development
    Table 136. LEO Pharma Corporation Information
    Table 137. LEO Pharma Description and Business Overview
    Table 138. LEO Pharma Tumor Necrosis Factor Inhibitor Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 139. LEO Pharma Product
    Table 140. LEO Pharma Recent Development
    Table 141. PROBIOMED Corporation Information
    Table 142. PROBIOMED Description and Business Overview
    Table 143. PROBIOMED Tumor Necrosis Factor Inhibitor Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 144. PROBIOMED Product
    Table 145. PROBIOMED Recent Development
    Table 146. Shanghai Pharmaceuticals Holding Co., Ltd. Corporation Information
    Table 147. Shanghai Pharmaceuticals Holding Co., Ltd. Description and Business Overview
    Table 148. Shanghai Pharmaceuticals Holding Co., Ltd. Tumor Necrosis Factor Inhibitor Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 149. Shanghai Pharmaceuticals Holding Co., Ltd. Product
    Table 150. Shanghai Pharmaceuticals Holding Co., Ltd. Recent Development
    Table 151. Tumor Necrosis Factor Inhibitor Drug Market Trends
    Table 152. Tumor Necrosis Factor Inhibitor Drug Market Drivers
    Table 153. Tumor Necrosis Factor Inhibitor Drug Market Challenges
    Table 154. Tumor Necrosis Factor Inhibitor Drug Market Restraints
    Table 155. Tumor Necrosis Factor Inhibitor Drug Customers List
    Table 156. Tumor Necrosis Factor Inhibitor Drug Distributors List
    Table 157. Research Programs/Design for This Report
    Table 158. Key Data Information from Secondary Sources
    Table 159. Key Data Information from Primary Sources
List of Figures
    Figure 1. Tumor Necrosis Factor Inhibitor Drug Product Picture
    Figure 2. Global Tumor Necrosis Factor Inhibitor Drug Sales Market Share by Type in 2020 & 2027
    Figure 3. Humira Product Picture
    Figure 4. Enbrel Product Picture
    Figure 5. Remicade Product Picture
    Figure 6. Simponi Product Picture
    Figure 7. Cimzia Product Picture
    Figure 8. Biosimilars Product Picture
    Figure 9. Global Tumor Necrosis Factor Inhibitor Drug Sales Market Share by Application in 2020 & 2027
    Figure 10. Rheumatoid Arthritis
    Figure 11. Psoriatic Arthritis
    Figure 12. Juvenile Idiopathic Arthritis
    Figure 13. Crohn’s Disease
    Figure 14. Ulcerative Colitis
    Figure 15. Others
    Figure 16. Tumor Necrosis Factor Inhibitor Drug Report Years Considered
    Figure 17. Global Tumor Necrosis Factor Inhibitor Drug Market Size, (US$ Million), 2016 VS 2021 VS 2027
    Figure 18. Global Tumor Necrosis Factor Inhibitor Drug Market Size 2016-2027 (US$ Million)
    Figure 19. Global Tumor Necrosis Factor Inhibitor Drug Sales 2016-2027 (K Units)
    Figure 20. Global Tumor Necrosis Factor Inhibitor Drug Market Size Market Share by Region: 2021 Versus 2027
    Figure 21. Global Tumor Necrosis Factor Inhibitor Drug Sales Market Share by Region (2016-2021)
    Figure 22. Global Tumor Necrosis Factor Inhibitor Drug Sales Market Share by Region in 2020
    Figure 23. Global Tumor Necrosis Factor Inhibitor Drug Revenue Market Share by Region (2016-2021)
    Figure 24. Global Tumor Necrosis Factor Inhibitor Drug Revenue Market Share by Region in 2020
    Figure 25. Global Tumor Necrosis Factor Inhibitor Drug Sales Share by Manufacturer in 2020
    Figure 26. The Top 10 and 5 Players Market Share by Tumor Necrosis Factor Inhibitor Drug Revenue in 2020
    Figure 27. Tumor Necrosis Factor Inhibitor Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
    Figure 28. Global Tumor Necrosis Factor Inhibitor Drug Sales Market Share by Type (2016-2021)
    Figure 29. Global Tumor Necrosis Factor Inhibitor Drug Sales Market Share by Type in 2020
    Figure 30. Global Tumor Necrosis Factor Inhibitor Drug Revenue Market Share by Type (2016-2021)
    Figure 31. Global Tumor Necrosis Factor Inhibitor Drug Revenue Market Share by Type in 2020
    Figure 32. Global Tumor Necrosis Factor Inhibitor Drug Sales Market Share by Application (2016-2021)
    Figure 33. Global Tumor Necrosis Factor Inhibitor Drug Sales Market Share by Application in 2020
    Figure 34. Global Tumor Necrosis Factor Inhibitor Drug Revenue Market Share by Application (2016-2021)
    Figure 35. Global Tumor Necrosis Factor Inhibitor Drug Revenue Market Share by Application in 2020
    Figure 36. United States Tumor Necrosis Factor Inhibitor Drug Sales Growth Rate 2016-2027 (K Units)
    Figure 37. United States Tumor Necrosis Factor Inhibitor Drug Revenue Growth Rate 2016-2027 (US$ Million)
    Figure 38. United States Tumor Necrosis Factor Inhibitor Drug Market Share in Global Market 2016-2027
    Figure 39. United States 5 and 10 Largest Tumor Necrosis Factor Inhibitor Drug Players Market Share by Revenue in Tumor Necrosis Factor Inhibitor Drug in 2020
    Figure 40. United States Tumor Necrosis Factor Inhibitor Drug Revenue Share by Type (2016-2021)
    Figure 41. United States Tumor Necrosis Factor Inhibitor Drug Revenue Growth Rate by Type in 2016 & 2020
    Figure 42. United States Tumor Necrosis Factor Inhibitor Drug Revenue Share by Application (2016-2021)
    Figure 43. United States Tumor Necrosis Factor Inhibitor Drug Revenue Growth Rate by Application in 2016 & 2020
    Figure 44. North America Tumor Necrosis Factor Inhibitor Drug Sales Growth Rate 2016-2021 (K Units)
    Figure 45. North America Tumor Necrosis Factor Inhibitor Drug Revenue Growth Rate 2016-2021 (US$ Million)
    Figure 46. North America Tumor Necrosis Factor Inhibitor Drug Sales Market Share by Country in 2020
    Figure 47. North America Tumor Necrosis Factor Inhibitor Drug Revenue Market Share by Country in 2020
    Figure 48. United States Tumor Necrosis Factor Inhibitor Drug Sales Growth Rate (2016-2021) (K Units)
    Figure 49. United States Tumor Necrosis Factor Inhibitor Drug Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 50. Canada Tumor Necrosis Factor Inhibitor Drug Sales Growth Rate (2016-2021) (K Units)
    Figure 51. Canada Tumor Necrosis Factor Inhibitor Drug Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 52. Europe Tumor Necrosis Factor Inhibitor Drug Sales Growth Rate 2016-2021 (K Units)
    Figure 53. Europe Tumor Necrosis Factor Inhibitor Drug Revenue Growth Rate 2016-2021 (US$ Million)
    Figure 54. Europe Tumor Necrosis Factor Inhibitor Drug Sales Market Share by Country in 2020
    Figure 55. Europe Tumor Necrosis Factor Inhibitor Drug Revenue Market Share by Country in 2020
    Figure 56. Germany Tumor Necrosis Factor Inhibitor Drug Sales Growth Rate (2016-2021) (K Units)
    Figure 57. Germany Tumor Necrosis Factor Inhibitor Drug Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 58. France Tumor Necrosis Factor Inhibitor Drug Sales Growth Rate (2016-2021) (K Units)
    Figure 59. France Tumor Necrosis Factor Inhibitor Drug Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 60. U.K. Tumor Necrosis Factor Inhibitor Drug Sales Growth Rate (2016-2021) (K Units)
    Figure 61. U.K. Tumor Necrosis Factor Inhibitor Drug Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 62. Italy Tumor Necrosis Factor Inhibitor Drug Sales Growth Rate (2016-2021) (K Units)
    Figure 63. Italy Tumor Necrosis Factor Inhibitor Drug Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 64. Russia Tumor Necrosis Factor Inhibitor Drug Sales Growth Rate (2016-2021) (K Units)
    Figure 65. Russia Tumor Necrosis Factor Inhibitor Drug Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 66. Asia Pacific Tumor Necrosis Factor Inhibitor Drug Sales Growth Rate 2016-2021 (K Units)
    Figure 67. Asia Pacific Tumor Necrosis Factor Inhibitor Drug Revenue Growth Rate 2016-2021 (US$ Million)
    Figure 68. Asia Pacific Tumor Necrosis Factor Inhibitor Drug Sales Market Share by Region in 2020
    Figure 69. Asia Pacific Tumor Necrosis Factor Inhibitor Drug Revenue Market Share by Region in 2020
    Figure 70. China Tumor Necrosis Factor Inhibitor Drug Sales Growth Rate (2016-2021) (K Units)
    Figure 71. China Tumor Necrosis Factor Inhibitor Drug Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 72. Japan Tumor Necrosis Factor Inhibitor Drug Sales Growth Rate (2016-2021) (K Units)
    Figure 73. Japan Tumor Necrosis Factor Inhibitor Drug Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 74. South Korea Tumor Necrosis Factor Inhibitor Drug Sales Growth Rate (2016-2021) (K Units)
    Figure 75. South Korea Tumor Necrosis Factor Inhibitor Drug Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 76. India Tumor Necrosis Factor Inhibitor Drug Sales Growth Rate (2016-2021) (K Units)
    Figure 77. India Tumor Necrosis Factor Inhibitor Drug Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 78. Australia Tumor Necrosis Factor Inhibitor Drug Sales Growth Rate (2016-2021) (K Units)
    Figure 79. Australia Tumor Necrosis Factor Inhibitor Drug Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 80. China Taiwan Tumor Necrosis Factor Inhibitor Drug Sales Growth Rate (2016-2021) (K Units)
    Figure 81. China Taiwan Tumor Necrosis Factor Inhibitor Drug Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 82. Indonesia Tumor Necrosis Factor Inhibitor Drug Sales Growth Rate (2016-2021) (K Units)
    Figure 83. Indonesia Tumor Necrosis Factor Inhibitor Drug Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 84. Thailand Tumor Necrosis Factor Inhibitor Drug Sales Growth Rate (2016-2021) (K Units)
    Figure 85. Thailand Tumor Necrosis Factor Inhibitor Drug Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 86. Malaysia Tumor Necrosis Factor Inhibitor Drug Sales Growth Rate (2016-2021) (K Units)
    Figure 87. Malaysia Tumor Necrosis Factor Inhibitor Drug Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 88. Latin America Tumor Necrosis Factor Inhibitor Drug Sales Growth Rate 2016-2021 (K Units)
    Figure 89. Latin America Tumor Necrosis Factor Inhibitor Drug Revenue Growth Rate 2016-2021 (US$ Million)
    Figure 90. Latin America Tumor Necrosis Factor Inhibitor Drug Sales Market Share by Country in 2020
    Figure 91. Latin America Tumor Necrosis Factor Inhibitor Drug Revenue Market Share by Country in 2020
    Figure 92. Mexico Tumor Necrosis Factor Inhibitor Drug Sales Growth Rate (2016-2021) (K Units)
    Figure 93. Mexico Tumor Necrosis Factor Inhibitor Drug Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 94. Brazil Tumor Necrosis Factor Inhibitor Drug Sales Growth Rate (2016-2021) (K Units)
    Figure 95. Brazil Tumor Necrosis Factor Inhibitor Drug Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 96. Argentina Tumor Necrosis Factor Inhibitor Drug Sales Growth Rate (2016-2021) (K Units)
    Figure 97. Argentina Tumor Necrosis Factor Inhibitor Drug Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 98. Middle East and Africa Tumor Necrosis Factor Inhibitor Drug Sales Growth Rate 2016-2021 (K Units)
    Figure 99. Middle East and Africa Tumor Necrosis Factor Inhibitor Drug Revenue Growth Rate 2016-2021 (US$ Million)
    Figure 100. Middle East and Africa Tumor Necrosis Factor Inhibitor Drug Sales Market Share by Country in 2020
    Figure 101. Middle East and Africa Tumor Necrosis Factor Inhibitor Drug Revenue Market Share by Country in 2020
    Figure 102. Turkey Tumor Necrosis Factor Inhibitor Drug Sales Growth Rate (2016-2021) (K Units)
    Figure 103. Turkey Tumor Necrosis Factor Inhibitor Drug Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 104. Saudi Arabia Tumor Necrosis Factor Inhibitor Drug Sales Growth Rate (2016-2021) (K Units)
    Figure 105. Saudi Arabia Tumor Necrosis Factor Inhibitor Drug Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 106. UAE Tumor Necrosis Factor Inhibitor Drug Sales Growth Rate (2016-2021) (K Units)
    Figure 107. UAE Tumor Necrosis Factor Inhibitor Drug Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 108. Tumor Necrosis Factor Inhibitor Drug Value Chain
    Figure 109. Channels of Distribution
    Figure 110. Distributors Profiles
    Figure 111. Bottom-up and Top-down Approaches for This Report
    Figure 112. Data Triangulation
    Figure 113. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
AbbVie Inc.
Amgen Inc.
Johnson & Johnson
UCB
Novartis AG
Pfizer, Inc.
Merck & Co., Inc.
CASI Pharmaceuticals
EPIRUS Biopharmaceuticals
LEO Pharma
PROBIOMED
Shanghai Pharmaceuticals Holding Co., Ltd.
Frequently Asked Questions
Tumor Necrosis Factor Inhibitor Drug report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Tumor Necrosis Factor Inhibitor Drug report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Tumor Necrosis Factor Inhibitor Drug report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Ceramic Wall Tiles

Ceramic Wall Tiles market is segmented by region (country), players, by Type, and by Application. ... Read More

Household Slicer

Household Slicer market is segmented by region (country), players, by Type, and by Application. P ... Read More

Plush Blankets

Plush Blankets market is segmented by region (country), players, by Type, and by Application. Pla ... Read More